The Fred Hutch Institutional Biosafety Committee (IBC) reviews, approves, and oversees research conducted in specific locations involving the use of recombinant or synthetic DNA/RNA and other biohazards (e.g., infectious agents).
Beginning June 1, 2025, approved minutes from all IBC meetings will be made publicly available here in accordance with NIH guidelines.